Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ophthotech Corp (NASDAQ:OPHT)

4.57
Delayed Data
As of 4:00pm ET
 +0.33 / +7.78%
Today’s Change
4.18
Today|||52-Week Range
65.96
-5.38%
Year-to-Date
No recent news for Ophthotech Corp.

Today’s Trading

Previous close4.24
Today’s open4.24
Day’s range4.23 - 4.60
Volume1,208,987
Average volume (3 months)2,321,228
Market cap$151.4M
Dividend yield--
Data as of 4:00pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)-3.73%
Earnings growth (this year)-69.58%
Earnings growth (next 5 years)--
Revenue growth (last year)+24.83%
P/E ratioNM
Price/Sales52.72
Price/Book2.49

Competitors

 Today’s
change
Today’s
% change
SMMTSummit Therapeutics ...+0.06+0.49%
ALBOAlbireo Pharma Inc+1.32+5.40%
OCXOncoCyte Corp+0.50+9.71%
VTLVital Therapies Inc+0.20+4.35%
Data as of 4:01pm ET, 02/27/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$1.70
Annual revenue (last year)$51.5M
Annual profit (last year)-$105.7M
Net profit margin-205.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
David R. Guyer
President, Chief Financial Officer &
Treasurer
Glenn P. Sblendorio
Corporate headquarters
New York, New York

Forecasts


Search for Jobs